Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle (FACE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01289444 |
Recruitment Status
:
Completed
First Posted
: February 3, 2011
Last Update Posted
: September 1, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Our goal is to advance palliative care to adolescents and their families. We hope our study will decrease suffering (psychological, spiritual, physical) and increase quality of life (QOL). Left unprepared for end-of-life decisions, miscommunication and disagreements may result in families being charged with neglect or court battles over treatment choices. FAmily CEntered (FACE) Advance Care Planning helps prepare adolescents with HIV/AIDS and their families for future medical decisions. We hope to increase families' understanding of their teens' wishes for end-of-life care and to decrease conflict. We will also study communication and spiritual struggle Families will be randomized into the either the Control (N=65 families) or FACE Intervention (N=65 families). FACE families will meet with a trained/certified researcher for three 60- to 90-minute sessions scheduled one week apart: Session 1: Lyon Advance Care Planning Survey© - Adolescent and Surrogate Versions: Session 2: The Respecting Choices Interview® Session 3: Completion of The Five Wishes©. Control families will also meet with a researcher for three 60-to 90-minute sessions scheduled one week apart: Session 1: Developmental History, Session 2: Safety Tips, and Session 3: Nutrition. Questionnaires will be administered five times, when first seen, at 3, 6, 12 and 18 months from the time of Session 3. Hypothesis 1: Compared to an active control, FACE will relieve psychological suffering by 1) increasing congruence in treatment preferences between teens with AIDS and their surrogates, 2) decreasing decisional conflict regarding EOL decision making for future medical treatment in adolescents with AIDS; 3) increasing quality communication about EOL care in adolescent/legal guardian or surrogate dyads; 4) and maximizing QOL.
Hypothesis 2: In addition to the direct effects, FACE will also indirectly affect QOL through dimensions of threat appraisal.
Hypothesis 3: FACE will have stronger effects on the QOL measures among patients who have less spiritual struggle.
Hypothesis 4: Spiritual struggle has both direct and indirect effects on hospitalization/dialysis use. FACE will also affect hospitalization/dialysis use indirectly through threat appraisal and HAART adherence.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV | Behavioral: FAmily CEntered (FACE) ACP Behavioral: Healthy Living Control | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 216 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Supportive Care |
Official Title: | Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle |
Actual Study Start Date : | July 2011 |
Actual Primary Completion Date : | July 2014 |
Actual Study Completion Date : | July 2014 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Healthy Living Control
Session 1. Developmental History. Goal: To take a non-medical developmental history. The RA-Control will conduct the session in a structured interview format. Administered, with all medical questions removed to prevent any risk of contamination with the experimental condition. Session 2. Safety Tips. Goal: To provide safety information using the American Academy of Pediatrics Bright Futures counseling guides. Participants will be asked questions about seat belt use, etc. Safety information will be provided. Session 3. Nutrition Tips. Goal: To provide safety information using the American Academy of Pediatrics Bright Futures nutrition/counseling guides. The Administered by the trained RA-Control to prevent contamination with the FACE condition. |
Behavioral: Healthy Living Control
Active Comparator: Three 60 to 90 minute sessions scheduled one week apart. 1. Developmental History. Goal: To take a non-medical developmental history. The RA-Control will conduct the session in a structured interview format. Administered with all medical questions removed to prevent any risk of contamination with the experimental condition. 2. Safety Tips. Goal: To provide safety information using the American Academy of Pediatrics Bright Futures counseling guides. Participants will be asked questions about seat belt use, etc. Safety information will be provided. 3. Nutrition Tips. Goal: To provide safety information using the American Academy of Pediatrics Bright Futures nutrition/counseling guides. Other Name: HLC
|
Experimental: FAmily CEntered (FACE) ACP
Three-60 to 90 minute sessions scheduled one week apart: 1) To assess values, spiritual and other beliefs, and life experiences with illness and EOL care & when to initiate advance care planning. 2) To facilitate conversations and shared decision-making between the adolescent and guardian/surrogate about palliative care & prepare the surrogate to be able to fully represent the adolescent's wishes. 3) Which person the teen wants to make health care decisions for him/her; The kind of medical treatment the teen wants; How comfortable the teen wants to be; How the teen wants people to treat him/her; What teen wants loved ones to know; Any spiritual or religious concerns teens may have.
|
Behavioral: FAmily CEntered (FACE) ACP
Three-60 to 90 minute sessions scheduled one week apart: 1) To assess values, spiritual and other beliefs, and life experiences with illness and EOL care & when to initiate advance care planning. 2) To facilitate conversations and shared decision-making between the adolescent and guardian/surrogate about palliative care & prepare the surrogate to be able to fully represent the adolescent's wishes. 3) Which person the teen wants to make health care decisions for him/her; The kind of medical treatment the teen wants; How comfortable the teen wants to be; How the teen wants people to treat him/her; What teen wants loved ones to know; Any spiritual or religious concerns teens may have.
Other Name: FACE
|
- congruence in treatment preferences [ Time Frame: Change from baseline in Congruence in Treatment Preferences at 18 months post-intervention compared to control ]Measured by the Statement of Treatment Preferences
- QOL [ Time Frame: Change from baseline in Quality of Life at 18 months post-intervention compared to control ]Measured by score on Varni's Peds QoL
- Utilization of hospitalization [ Time Frame: Change from baseline in hospitalizations at 18 month follow-up post intervention compared to control ]Hospitalization will be measured by chart review. Each site has hospital based services for patient population
- Utilization of dialysis [ Time Frame: Change from baseline in use of dialysis at 18 month post-intervention compared to control ]Use of dialysis will be measured by chart review.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 14 Years to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Adolescent Inclusion Criteria:
- Diagnosed ever with HIV;
- All ethnic groups;
- Knows HIV status;
- Speaks English;
- Absence of active homicidality or suicidality;
- Absence of HIV dementia;
- IQ >69;
- Consent from the legal guardian for adolescents aged 14-17;
- Consent from the surrogate for adolescents aged 18-21;
- Assent from adolescent aged 14-17;
- Consent from adolescent aged 18-21;
- Absence of severe depression;
- Not in foster care
Legal Guardian Inclusion Criteria for Legal Guardians of Adolescents Age 14-17:
- Adolescent willingness to discuss problems related to HIV/AIDS with them;
- Age 18 or older;
- Ability to speak English;
- Absence of active homicidality, suicidality, or psychosis;
- Absence of HIV dementia;
- Legal guardian;
- Consent to participate; Consent for his/her adolescent to participate;
- Knows HIV status of adolescent;
- Absence of depression in the severe range;
Surrogate Inclusion Criteria for Adolescents Age 18-21:
- Selected by adolescent aged 18 to 21;
- Age 18 or older;
- Willingness to discuss problems related to HIV and end-of-life;
- Absence of active homicidality, suicidality, or psychosis;
- Absence of HIV dementia;
- Speaks English;
- Consent to participate;
- Knows HIV status of adolescent.
- Absence of severe depression;
Exclusion Criteria:
- adolescent or surrogate does not know HIV diagnosis
- being in foster care
- developmentally delayed
- scoring below the cut off on the HIV Dementia Scale
- scoring above the cut off for depressive symptoms on the Beck Depression Inventory
- homicidal, suicidal or psychotic on screening
- does not speak English

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01289444
United States, District of Columbia | |
Howard University Hospital | |
Washington, D.C., District of Columbia, United States, 20060 | |
Children's National Medical Center | |
Washington, D.C., District of Columbia, United States, 22314 | |
United States, Florida | |
Children's Diagnostic & Treatment Center (Broward Health) | |
Fort Lauderdale, Florida, United States, 33316 | |
Univeristy of Miami Miller School of Medicine | |
Miami, Florida, United States, 33136 | |
United States, Tennessee | |
St. Jude Children's Research Hospital | |
Memphis, Tennessee, United States, 38105 |
Principal Investigator: | Maureen E Lyon, PhD | Children's Research Institute |
Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Maureen Lyon, Principal Investigator, Children's Research Institute |
ClinicalTrials.gov Identifier: | NCT01289444 History of Changes |
Other Study ID Numbers: |
1R01NR012711-01 ( U.S. NIH Grant/Contract ) |
First Posted: | February 3, 2011 Key Record Dates |
Last Update Posted: | September 1, 2017 |
Last Verified: | August 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | De-identified participant data will be shared upon request to the PI after the close of the study. |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) |
Time Frame: | September 1, 2017 to September 1, 2020 |
Access Criteria: | Graduate students in accredited programs, residents, fellows, faculty in accredited programs. |
Keywords provided by Maureen Lyon, Children's Research Institute:
palliative care AIDS adolescents quality of life adherence spiritual threat appraisal treatment congruence treatment preferences |
dialysis hospitalization communication family intervention Family Centered Advance Care Planning decision making advance care planning end of life |